Search clinical trials for: Risk of red blood cells concentrates transfusion

Total 445283 results

Clinica Universidad de Navarra, Universidad de...
Hospital Clinic of Barcelona; Hospital Son Espases; Hospital del Mar; Hospital... and other collaborators

Active, not recruiting

Predictive Model to Calculate the Risk of RBC Transfusion in Elective Brain Tumours Resections (TScoreBTR) (TScoreBTR)

Surgery | Brain Tumor Adult | Transfusion

Spain
Cerus Corporation

Recruiting

INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections (RedeS)

Anemia

United States, Puerto Rico
Fundación General de la Universidad de Salamanca
Celgene Corporation

Completed

Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome (SINTRA-REV)

Myelodysplastic Syndrome

Germany, Spain, France
Fundación Universitaria de Ciencias de la Salud
Hospital de San Jose

Completed

Is Red Blood Cell Transfusion a Risk Factor for Vascular Pedicle Thrombosis? The Study Case of a Latin American Cohort (RBCT)

Vascular Thrombosis
University of Sao Paulo General Hospital

Completed

Strategy of Transfusion in Trauma Patients - STATA Trial (STATA)

Wounds and Injuries

Brazil
Unity Health Toronto
Canadian Blood Services

Completed

Transfusion Triggers in Cardiac Surgery (TTRICS)

Cardiac Surgery

Canada
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Randomized Trial Of Platelet Transfusion Policies After Blood Stem Cells Transplantation In Young Children: Reduction Of Number Of Single Platelet Concentrate Donors Per Child

Children Treated With High-Dose Chemotherapy (HDC) Followed by Haematopoietic Stem Cell Transplantation (HSCT)

France
Bristol-Myers Squibb

Recruiting

A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants (MAXILUS)

Myelodysplastic Syndromes

Spain, United States, France, Italy, Belgium, Germany, Poland, Czechia, Puerto Rico
Central Hospital, Nancy, France

Not yet recruiting

Evaluation of the 1-year Prognosis of Patients Under Veno-arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock With Blood Transfusion Requirement (HemoECMO)

Extracorporeal Membrane Oxygenation Complication | Transfusion Related Complication | Blood Cells Transfusion
University of Alabama at Birmingham
The University of Texas Health Science Center, Houston; National Heart, Lung...

Recruiting

Trauma Resuscitation With Low-Titer Group O Whole Blood or Products (TROOP)

Wounds and Injuries | Shock, Hemorrhagic

United States
Hospital Clinic of Barcelona
Institut d'Investigacions Biomèdiques August Pi i Sunyer; Banc de Sang i Teixits

Not yet recruiting

Red Blood Cells From Umbilical Cord for Transfusion of Preterm Infants

Infant, Extremely Premature | Erythrocyte Transfusion | Umbilical Cord Issue
LanZhou University
Beigene (Beijing) Biotechnology Co., Ltd

Not yet recruiting

Zanubrutinib in Maintenance Therapy of DLBCL Patients With Initial Remission

Diffuse Large B-cell Lymphoma (DLBCL)

China
University of Leipzig
Deutsche Krebshilfe e.V., Bonn (Germany)

Recruiting

Study Investigating Patient-Reported Outcomes in Lower-risk MDS Patients (PRO-RED)

MDS | MDS/MPN

Germany, Austria
Boston Children's Hospital

Recruiting

Trial of Indication-Based Transfusion of Red Blood Cells in ECMO (TITRE)

Extracorporeal Membrane Oxygenation | Red Blood Cell Transfusion | Organ Failure, Multiple

United States, Canada, Australia
Fondazione Policlinico Universitario Agostino Gemelli...
Fresenius Hemocare

Recruiting

umBilical Or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity (BORN) (BORN)

Retinopathy of Prematurity

Italy
Fundacion CRIS de Investigación para Vencer el...
BTG International Inc.; BioClever 2005 S.L.; Eurofins ADME, S.L.; NTShub, S.L.

Recruiting

Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS

Diffuse Large B-Cell Lymphoma | Drug Toxicity

Spain
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge

Recruiting

Molecular Investigation of GENetic Factors in Cardiovascular and Immune-related Traits and Diseases Using a BIOresource of Healthy Volunteers (GENBIO) (GENBIO)

Cardiovascular Diseases

United Kingdom
University of Edinburgh
University of Oxford

Recruiting

ABC - A Post Intensive Care Anaemia Management Trial

Quality of Life | Fatigue | Physical Disability | Anemia Acute

United Kingdom
Emory University
National Heart, Lung, and Blood Institute (NHLBI); Cerus Corporation

Recruiting

Red Blood Cell Survival in Sickle Cell Disease

Sickle Cell Disease

United States
Keros Therapeutics, Inc.

Recruiting

A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes

Myelodysplastic Syndromes | Cytopenia

Australia, Spain, United States, Israel, France, Germany, New Zealand, Czechia
Stephan Grupp MD PhD
University of Pennsylvania

Recruiting

Orphan Indications for CD19 Redirected Autologous T Cells

Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL | Infants With Very High Risk KMT2A B-ALL | Patients With Central Nervous System Relapse Who Did Not Receive Cranial Radiation or Bone Marrow Transplantation

United States
Children's Hospital of Philadelphia
National Heart, Lung, and Blood Institute (NHLBI); New York Blood Center

Recruiting

RH Genotype Matched RBC Transfusions (RBC)

Sickle Cells Disease

United States
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; Etablissement... and other collaborators

Recruiting

Biological Parameters Changes After Autologous Blood Transfusion of Red Blood Cells (200 ml) in Healthy Volunteers. (AUTOT-SPORT)

The Focus is on the Detection of the Consequences of Autologous Blood Transfusion in Healthy Volunteers

France
Daping Hospital and the Research Institute of Surgery...

Recruiting

Transfusion of Red Blood Cells for Acute Respiratory Distress Syndrome(ARDS) in Neonates

Acute Respiratory Distress Syndrome (ARDS) | Red Blood Cells(RBC)

China
Masonic Cancer Center, University of Minnesota

Recruiting

Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies

Sickle Cell Disease | Severe Congenital Neutropenia | Paroxysmal Nocturnal Hemoglobinuria | Glanzmann Thrombasthenia | Shwachman-Diamond Syndrome | Diamond Blackfan Anemia | Transfusion Dependent Alpha- or Beta- Thalassemia | Non-Malignant Hematologic Disorders

United States
Children's Hospital Medical Center, Cincinnati
Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Center

Recruiting

HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

Fanconi Anemia | Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML) | Severe Marrow Failure

United States
CHU de Quebec-Universite Laval
Canadian Institutes of Health Research (CIHR); Canadian Critical Care Trials... and other collaborators

Completed

HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial (HEMOTION)

Traumatic Brain Injury | Transfusion

Canada, United Kingdom, Brazil, France
Takeda
Takeda Development Center Americas, Inc.

Active, not recruiting

Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) (PANTHER)

Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Myelodysplastic Syndrome

Australia, United States, Canada, Spain, Belgium, France, Czechia, Italy, Korea, Republic of, Israel, Brazil, China, Germany, Turkey, Japan, Greece, Poland, United Kingdom, Russian Federation, Mexico
Bristol-Myers Squibb

Active, not recruiting

Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan

Lower-risk Myelodysplastic Syndromes

Japan
FibroGen
AstraZeneca; Astellas Pharma Inc

Terminated

Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden

Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)

United States, Australia, Belgium, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, United Kingdom, France, Turkey, Canada, Denmark, India, Poland
Istituto Auxologico Italiano
European Society of Hypertension; Chinese Hypertension League

Completed

Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives (ESH-CHL-SHOT)

Stroke | Hypertension | Transient Ischemic Attack

Russian Federation
Terumo BCTbio
United States Department of Defense; U.S. Army Medical Research and Development... and other collaborators

Terminated

Efficacy and Safety of RBCs Derived From Mirasol-treated Whole Blood in Patients Requiring Chronic Transfusion (PRAISE) (PRAISE)

Transfusion Dependent Thalassemia

United States, Israel, Italy, Turkey
Celgene

Completed

The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome

United States, Australia, Canada, Czechia, France, Germany, Italy, Korea, Republic of, Mexico, Poland, Sweden, United Kingdom, Belgium, Brazil, Denmark, Finland, Greece, Israel, Netherlands, Norway, Portugal, Spain, Turkey
Banc de Sang i Teixits
Sistema d'Emergències Mèdiques (SEM); IDIBGI (Institut d'Investigació Biomèdica...

Completed

Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage at Pre-hospital Phase of Care. (PRETIC)

Polytrauma | Traumatic Hemorrhage

Spain
Rare Partners srl Impresa Sociale
Università degli Studi di Ferrara

Completed

Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients (SIRTHALACLIN)

Beta-Thalassemia

Italy
Population Health Research Institute

Active, not recruiting

Small-Volume Tubes to Reduce Anemia and Transfusion (STRATUS)

Blood Loss Anemia

Canada
Sanquin-LUMC J.J van Rood Center for Clinical Transfusion...

Completed

Mortality After Transfusion of Ever-pregnant Donor Red Blood Cells (MATER)

Anemia

Netherlands
Celgene
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...

Active, not recruiting

A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve (COMMANDS)

Myelodysplastic Syndromes

United States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Lithuania, Netherlands, Poland, Portugal, Russian Federation, Spain, Sweden, Switzerland, Taiwan, Turke... and more
Celgene

Active, not recruiting

A Study to Evaluate the Efficacy, Drug Levels and Safety of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes in Chinese and Japanese Participants With Ring Sideroblasts Who Require Red Blood Cell Transfusions

Myelodysplastic Syndromes

China, Japan
Cristina Martinez

Completed

Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage

Hemorrhagic Shock

Spain
Cristina Martinez

Completed

Pilot Study on the Use of Hydrocortisone, Vitamin c and Tiamine in Patient With Sepsis and Septic Shock

Sepsis | Septic Shock

Spain
Memorial Sloan Kettering Cancer Center

Active, not recruiting

ß-Thalassemia Major With Autologous CD34+ Hematopoietic Progenitor Cells Transduced With TNS9.3.55 a Lentiviral Vector Encoding the Normal Human ß-Globin Gene

Confirmed Diagnosis of ß-thalassemia Major

United States
Celgene

Completed

An Efficacy and Safety Study of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in Japanese Subjects Who Are Not Requiring Red Blood Cell Transfusion

Myelodysplastic Syndromes

Japan
Emory University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Transfusion of Biotinylated Red Blood Cells (b-RBCs)

Anemia

United States
McMaster University
Canadian Institutes of Health Research (CIHR)

Completed

Pilot Study of Sex-matched vs. Sex-mismatched Red Blood Cell Transfusion

Blood Transfusion

Canada
Ruijin Hospital

Active, not recruiting

Reduced Chemotherapy in Low Risk DLBCL

Diffuse Large B-cell Lymphoma

China
Università degli Studi di Ferrara

Completed

Effects of Red Blood Cells Transfusion on Renal Blood Flow

Anemia | Acute Kidney Injury | Fluid Overload | Transfusion-Associated Circulatory Overload

Italy
University of Campania "Luigi Vanvitelli"
University of Alabama at Birmingham; Federico II University; Monaldi Hospital

Completed

Network Medicine Approaches to Classify Heart Failure With PReserved Ejection Fraction by Signatures of DNA Methylation and Point-of-carE Risk calculaTors (PRESMET) (PRESMET)

Atrial Fibrillation | Pulmonary Hypertension | Heart Failure, Diastolic | Heart Failure, Systolic

Italy
Gladwin, Mark, MD
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Transfusion of Biotin-Labeled Red Blood Cells

Healthy Volunteers

United States
Columbia University
National Heart, Lung, and Blood Institute (NHLBI); New York Blood Center

Active, not recruiting

Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality (DIDS)

Iron Deficiency

United States

Search clinical trials for: Risk of red blood cells concentrates transfusion

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations